INSTITUTION'S PROFILE

University of North Carolina (UNC) at Chapel Hill, Chapel Hill, NC, USA.

Publications (1)

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.

Journal: Lancet (London, England)

Publication date: 2022

Journal: Lancet (London, England)

Publication Year: 2022

Authors & Co-authors:  Delany-Moretlwe Hughes Bock Ouma Hunidzarira Kalonji Kayange Makhema Mandima Mathew